AzTrials
AzTrials

Chronic Lower Back PainNCT06619418

Assessment of Usability and Satisfaction With a Take-home Device Presenting Sound and Body Stimulation for Back Pain

A study testing TENS device and Integrative health modalities in people with Chronic Lower Back Pain, run by University of Minnesota at 1 site in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Pain symptoms can have a variety of ways to be treated, from medications to physical therapy, with several options being available to patients. However, no one treatment may work for all people who experience pain, especially cLBP. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Chronic Lower Back Pain
What is being tested?
TENS device and Integrative health modalities
Could I receive a placebo?
No, everyone receives an active treatment
How many people
20 participants
Where
1 siteUnited States
Study dates
18 Nov 2024to 11 Aug 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Must be 18 years of age or older
  • Must be within commuting distance to the University of Minnesota
  • Able to provide consent and follow study instructions
  • Must be able to understand English
  • Must have chronic LBP, which is defined as lower back pain for more than 3 months
  • A score of 4 or higher on the PEG
  • Must be willing to commit to full duration of the study
  • Not currently taking any benzodiazepines or sedative hypnotics

Who cannot join

  • Back Pain associated with:
  • Spondylolisthesis or spinal stenosis
  • Sciatica or radiculopathy
  • Rhematologic or inflammatory disease
  • Trauma, fracture, dislocation, or previous back surgery
  • A score of 10 on the PEG
Show all 14Show fewer
  • Pregnant
  • Have an electrically implanted device, such as a pacemaker.
  • Heart Disease
  • Epilepsy
  • Cancer
  • Psychiatric conditions including psychosis, suicidal ideation, or substance abuse disorder
  • A pure tone average of more than 40 dB HL at 500 dB, 1000 dB, or 2000 dB HL.
  • Individuals currently using other lower back pain treatments during the study in which they are unable to maintain a steady state while participating in our study for one month before beginning the multi-modal regimen.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Grace Conchas contact

buchh123@umn.edu

United States1 site, 1 recruiting
  • University of Minnesota

    Minneapolis, Minnesota, 55414

    Grace Conchas, bunchh123@umn.edu

    Recruiting

Other trials in United States

About this study

Pain symptoms can have a variety of ways to be treated, from medications to physical therapy, with several options being available to patients. However, no one treatment may work for all people who experience pain, especially cLBP. The purpose of this study is to measure the compliance, usability, and satisfaction of an at-home, multi-modal stimulation device in a diverse population of people with chronic lower back pain (cLBP). The multi-modal device will include a combination of electrical stimulation, auditory stimulation, and integrative-health techniques, including mindfulness breathing, health coaching, and reflective journaling. The multi-modal device creation is based on prior knowledge in lower back pain treatment, which includes electrical stimulation of the back (Transcutaneous Electrical Nerve Stimulator or TENS) and integrative health modalities. In isolation, these treatments are only somewhat effective in reducing symptoms.

This pilot study will involve participants who experience cLBP as we investigate a novel at-home, multi-modal device design. The main objective of the pilot usability study is to examine compliance to the intended use of the multi-modal device and approach, as well as protocol feasibility, and satisfaction with the settings and design.

Being tested
TENS device, Integrative health modalities

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • TENS deviceDevice

    will be using an FDA- cleared TENS device for electrical stimulation (TENS 7000, Compass Health Brands) in combination with commercially-available headphones for acoustic stimulation (AKG 845 BT).Will be shown how to use the device, trained on the multimodal stimulation procedure, and sent home with the device for 12 weeks.

  • Integrative health modalitiesBehavioural

    will be instructed on the integrative health modalities for this study. They will be given a tablet that includes the videos for the visually guided deep breathing. They will also receive the reflective journal and be set up for health coaching visits. At the end of the 12 weeks, this group of participants will return to the U of M campus and complete an interview about satisfaction and usability of the IH modalities.

Study groups in NCT06619418
Study groupRoleWhat they receive
device groupExperimentalNot described
Receives: Device: TENS device
Integrative health modality groupActive comparatorNot described
Receives: Behavioral: Integrative health modalities

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. compliance rate

    Measure compliance in terms of time using the integrative health devices and the multi-modal stimulation device over a period of 12 weeks to determine the effect on participant compliance by adding electrical stimulation to the device.

    Measured: 12 weeks

Secondary outcomes (1)
  1. satisfaction rate

    relating to usability of an at-home multi-modal stimulation approach and device and integrative health practices..

    Measured: 12 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted1 Oct 2024
  2. Study start18 Nov 2024
  3. Primary completion11 Aug 2027 (estimated)
  4. Study completion11 Aug 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Device feasibility
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
20 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06619418
Sponsor's protocol ID
ENT-2024-33112
Status last verified
Aug 2026
First submitted
17 Jul 2024
Last updated
20 Aug 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
Yes

Questions about this trial

What is this clinical trial studying?

A study testing TENS device and Integrative health modalities in people with Chronic Lower Back Pain, run by University of Minnesota at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 8 inclusion and 14 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 20 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Grace Conchas (buchh123@umn.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

compliance rate (time frame: 12 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Aug 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in